4don MSN
Immune memory cells in ovarian cancer produce tumor-targeting antibodies, opening a vaccine path
While we tend to quickly forget having been ill or having received a vaccine, the immune system remembers remarkably well. It ...
Chris and Xand continue their conversation about the lymphatic system with Professor Kristiana Gordon, a Consultant in ...
The Times of Israel on MSN
In a world first, Israeli scientists find ‘memory’ B cells can target ovarian tumors
Immune cells not only remember viruses, but can also secrete tumor-fighting antibodies, say Weizmann Institute researchers; ...
While we tend to quickly forget having been ill or having received a vaccine, the immune system remembers remarkably well. It ...
Breakthroughs on Parkinson's could lead to treatments for other brain ills like Lewy body dementia and Alzheimer's.
The new 'Longevity and Age-Related Diseases” outpatient clinic at Medicana Zincirlikuyu Hospital introduces a holistic ...
AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved DECNUPAZTM (pivekimab sunirine-pvzy) for the treatment of adult patients with BPDCN, an ultra-rare and ...
US FDA approves AbbVie’s Decnupaz to treat adult patients with blastic plasmacytoid dendritic cell neoplasm: North Chicago Friday, May 29, 2026, 17:00 Hrs [IST] AbbVie announced ...
The human body thrives on essential metals, but excessive exposure can cause a variety of issues for them in the long run, ...
DECNUPAZ is the first and only antibody-drug conjugate (ADC) approved for blastic plasmacytoid dendritic cell neoplasm (BPDCN) that is initiated in an outpatient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results